Physician profile
Daryn N Hatmaker
NPI 1033815758
$196.00
in general payments reported to CMS, 2019-2025
9 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $93.54 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $196.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $45.06 | 2024 | Linvatec Arthroscopy |
| Exeltis, USA INC. | $31.36 | 2024 | Slynd |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $22.22 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $18.85 | 2025 | Auvelity |
| Medtronic, INC. | $17.17 | 2025 | Minimed 780g |
| Philips North America LLC | $17.12 | 2024 | (Ck7) Extended Holter |
| Astrazeneca Pharmaceuticals LP | $15.99 | 2025 | Airsupra |
| Neos Therapeutics, LP | $14.63 | 2025 | Adzenys Xr-Odt |
| Cequr Corporation | $13.60 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryn Hatmaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.